| Financial Year |
March 31 2023 |
| Monetary Funds |
90,675,562,286.06 |
| Held-for-trading Financial Assets |
67,332,482,089.76 |
| Notes Receivable |
-- |
| Accounts Receivable |
799,735,465.65 |
| Advances to Suppliers |
224,109,638.46 |
| Other Receivables |
3,285,564,716.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,724,400.00 |
| Dividend Receivable |
35,208,919.78 |
| Inventories |
173,970,781.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,165,486,820.40 |
| Other Current Assets |
44,080,376,457.34 |
| Total Current Assets |
250,728,865,632.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,453,836,767.93 |
| Investment Properties |
54,717,467.21 |
| Fixed Assetes |
1,782,565,629.04 |
| Under-construction Projects |
123,031,749.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
880,661,626.78 |
| R&D expenses |
-- |
| Goodwill |
4,598,942,255.02 |
| Long-Term Deferred and Prepaid Expenses |
98,372,991.61 |
| Deferred Income Tax Assets |
788,412,931.41 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
59,300,962,740.03 |
| Total Assets |
310,029,828,372.71 |
| Short-Term Loans |
54,861,884.77 |
| Trading Financial liabilities |
10,378,731,329.65 |
| Notes Payable |
-- |
| Accounts Payable |
206,802,573.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,454,652,025.11 |
| Taxes Payable |
498,314,246.17 |
| Interest Payable |
8,884,643.46 |
| Dividend Payable |
39,437,808.22 |
| Other payables |
12,327,906,604.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,846,018,674.03 |
| Other Current Liabilities |
13,807,908,419.26 |
| Sub-Total of Current Liabilities |
204,754,758,328.54 |
| Long-term Loans |
3,403,643,130.55 |
| Bonds Payable |
43,104,365,787.47 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,273,702.79 |
| Deferred Income Tax Liabilities |
386,485,359.28 |
| Other Non-Current Liabilities |
2,108,206.68 |
| Sub-Total of Non-Current Liabilities |
47,543,308,147.29 |
| Total Liabilities |
252,298,066,475.83 |
| Paid-In Capital(Or Share Stock) |
6,425,306,261.00 |
| Capital Surplus |
18,331,023,998.20 |
| Surplus Reserve |
597,580,843.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
18,254,397,890.09 |
| Minority Stockholder's Interest |
5,551,644,736.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
52,180,117,159.99 |
| Owner's Equity（Stockholder's Equity） |
57,731,761,896.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
310,029,828,372.71 |
